Keros Therapeutics, Inc. Ttl Offset Amt
Keros Therapeutics, Inc. (KROS) had Ttl Offset Amt of $0 as of 2026-09-09, per its S-3 filed 2026-09-10.
Financial Statements › Notes
ffd:TtlOffsetAmt · last filed 2026-09-10
- 2026-09-09: Ttl Offset Amt $0.00.
| Period end | Ttl Offset Amt |
|---|---|
| 2026-09-09 | $0.00 S-3 · filed 2026-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |